triCitrasol (Citra Labs LLC)


Welcome to the PulseAid listing for the triCitrasol drug offered from Citra Labs LLC. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Citra Labs LLC
NON-PROPRIETARY NAME: Trisodium Citrate dihydrate
SUBSTANCE NAME: TRISODIUM CITRATE DIHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
ROUTE: EXTRACORPOREAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2003-07-10
END MARKETING DATE: 0000-00-00


triCitrasol HUMAN PRESCRIPTION DRUG Details:

Item DescriptiontriCitrasol from Citra Labs LLC
LABELER NAME: Citra Labs LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 0.467(g/mL)
START MARKETING DATE: 2003-07-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 23731-6030_bec85982-49c5-47ef-b16e-73f61ce4bf81
PRODUCT NDC: 23731-6030
APPLICATION NUMBER: BN010409

Other TRISODIUM CITRATE DIHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alva-Amco Pharmacal Companies, Inc.Nauzene
Citra Labs LLCtriCitrasol
Fenwal, Inc.Sodium Citrate Blood-Pack Units, (PL 146 Plastic)
Fresenius Kabi USA, LLCSodium Citrate Blood-Pack Units, (PL 146 Plastic)
Haemonetics CorporationHaemonetics Anticoagulant Sodium Citrate